These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26858119)

  • 1. The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine.
    Madamet M; Briolant S; Amalvict R; Benoit N; Bouchiba H; Cren J; Pradines B;
    Parasit Vectors; 2016 Feb; 9():77. PubMed ID: 26858119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates.
    Foguim FT; Bogreau H; Gendrot M; Mosnier J; Fonta I; Benoit N; Amalvict R; Madamet M; Wein S; Pradines B;
    Malar J; 2020 Jun; 19(1):201. PubMed ID: 32503540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum.
    Pradines B; Briolant S; Henry M; Oeuvray C; Baret E; Amalvict R; Didillon E; Rogier C
    Malar J; 2010 Nov; 9():339. PubMed ID: 21108786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Sensitivity of Pyronaridine in Thai Isolates of
    Mahotorn K; Tan-Ariya P; Thita T; Ruang-Areerate T; Sittichot N; Suwandittakul N; Mungthin M
    Am J Trop Med Hyg; 2018 Jan; 98(1):51-56. PubMed ID: 29141758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene.
    Pascual A; Madamet M; Bertaux L; Amalvict R; Benoit N; Travers D; Cren J; Taudon N; Rogier C; Parzy D; Pradines B;
    Malar J; 2013 Nov; 12():431. PubMed ID: 24274185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the Pfatpase 6 and Pfcrt gene and their relationship with the in vitro susceptibility to dihydroartemisinin and chloroquine of Plasmodium falciparum isolates from Abobo, Côte d'Ivoire.
    Bla BK; Yavo W; Trébissou J; Kipré RG; Yapi FH; N'guessan JD; Djaman JA
    Ann Parasitol; 2014; 60(4):259-66. PubMed ID: 25706423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of PfCRT K76T mutation in Plasmodium falciparum isolates in Ghana.
    Afoakwah R; Boampong JN; Egyir-Yawson A; Nwaefuna EK; Verner ON; Asare KK
    Acta Trop; 2014 Aug; 136():32-6. PubMed ID: 24727053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
    Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
    Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
    Ojurongbe O; Ogungbamigbe TO; Fagbenro-Beyioku AF; Fendel R; Kremsner PG; Kun JF
    Malar J; 2007 Apr; 6():41. PubMed ID: 17428334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of Plasmodium falciparum isolates from Abidjan, Côte d'Ivoire, to artemisinin, chloroquine, dihydroartemisinin and pyronaridine.
    Brice BK; William Y; Lacina O; Félix Y; Hugues A; Léonardo B; André M; Joseph D
    Tanzan J Health Res; 2010 Jan; 12(1):73-9. PubMed ID: 20737832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.
    Kurth F; Pongratz P; Bélard S; Mordmüller B; Kremsner PG; Ramharter M
    Malar J; 2009 Apr; 8():79. PubMed ID: 19389221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents.
    Pradines B; Tall A; Parzy D; Spiegel A; Fusai T; Hienne R; Trape JF; Doury JC
    J Antimicrob Chemother; 1998 Sep; 42(3):333-9. PubMed ID: 9786473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pfcrt mutant haplotypes may not correspond with chloroquine resistance.
    Goswami D; Dhiman S; Rabha B; Kumar D; Baruah I; Sharma DK; Veer V
    J Infect Dev Ctries; 2014 Jun; 8(6):768-73. PubMed ID: 24916876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine.
    Pradines B; Mabika Mamfoumbi M; Parzy D; Owono Medang M; Lebeau C; Mourou Mbina JR; Doury JC; Kombila M
    Am J Trop Med Hyg; 1999 Jan; 60(1):105-8. PubMed ID: 9988332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.
    Pascual A; Parola P; Benoit-Vical F; Simon F; Malvy D; Picot S; Delaunay P; Basset D; Maubon D; Faugère B; Ménard G; Bourgeois N; Oeuvray C; Didillon E; Rogier C; Pradines B
    Malar J; 2012 Feb; 11():45. PubMed ID: 22333675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India.
    Keen J; Farcas GA; Zhong K; Yohanna S; Dunne MW; Kain KC
    J Clin Microbiol; 2007 Sep; 45(9):2889-93. PubMed ID: 17609321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational prevalence of chloroquine resistance transporter gene among Plasmodium falciparum field isolates in Assam and Arunachal Pradesh, India.
    Sharma J; Soni M; Dutta P; Khan SA; Mahanta J
    Indian J Med Microbiol; 2016; 34(2):193-7. PubMed ID: 27080771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant Plasmodium falciparum chloroquine resistance transporter in Hodeidah, Yemen: association with parasitologic indices and treatment-seeking behaviors.
    Abdul-Ghani R; Farag HF; Allam AF; Shawky SM; Al-Mekhlafi AM
    Acta Trop; 2013 Dec; 128(3):473-8. PubMed ID: 23906615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial activity of isoquine against Kenyan Plasmodium falciparum clinical isolates and association with polymorphisms in pfcrt and pfmdr1 genes.
    Okombo J; Kiara SM; Abdirahman A; Mwai L; Ohuma E; Borrmann S; Nzila A; Ward S
    J Antimicrob Chemother; 2013 Apr; 68(4):786-8. PubMed ID: 23169890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.